Publications
5674 Results
- Journal / Conference
- Journal of the National Cancer Institute, Aug 2;113(8):989-996
- Year
- 2021
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID33629114
- PMC
- PMC8328987
- Study Number(s)
- S1105
Patient Reported Outcomes and Long-Term Non-Adherence to Aromatase Inhibitors
- Journal / Conference
- International Journal of Cancer Apr 1;148(7):1625-1636
- Year
- 2021
- Research Committee(s)
- Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID33038280
- PMC
- PMC7894468
- Study Number(s)
- S0000
Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study
- Journal / Conference
- Prostate Cancer and Prostatic Diseases, Jun;24(2):532-541
- Year
- 2021
- Research Committee(s)
- Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID33420416
- PMC
- PMC8157993
- Study Number(s)
- S0000, SWOG-9217
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer
- Journal / Conference
- Cancer Research Jun 1;81(11):3134-3143; Feb 11;canres.3267.2020. doi: 10.1158/0008-5472.CAN-20-3267. Online ahead of print
- Year
- 2021
- Research Committee(s)
- Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID33574088
- PMC
- PMC8178175
- Study Number(s)
- S0000
Smoking modifies pancreatic cancer risk loci on 2q21.3
- Journal / Conference
- Evaluation and the Health Professions Mar;44(1):42-49
- Year
- 2021
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID33506704
- PMC
- PMC8279086
- Study Number(s)
- S0000
A Latent Disease Model to Reduce Detection Bias in Cancer Risk Prediction Studies
- Journal / Conference
- Journal of Oncology Practice Nov;17(11): e1821-e1829
- Year
- 2021
- Research Committee(s)
- Cancer Care Delivery and Lung
- PMID
- PMID33797955
Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (LungMAP SWOG S1400GEN)
- Journal / Conference
- Lancet Feb 20;397(10275):695-703. doi: 10.1016/S0140-6736(21)00152-5. Epub 2021 Feb 13.
- Year
- 2021
- Research Committee(s)
- Genitourinary
- PMID
- PMID33592176
- PMC
- PMC8687736
- Study Number(s)
- S1500
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 6; abstr 270); ASCO GU Cancers Sympos (Feb 13-15, 2021), oral
- Year
- 2021
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1500
Sunitinib versus cabozantinib, crizotinib or savolitinib in metastatic papillary renal cell carcinoma (pRCC): Results from the randomized phase II SWOG 1500 study
- Journal / Conference
- American Association for Cancer Research (Week 1: April 10-15; Week 2: May 17-21, 2021 virtual) LBA, oral
- Year
- 2021
- Research Committee(s)
- Cancer Control, Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000, SWOG-9217
Meta-analysis in more than 80,000 men of African ancestry identified eight novel variants associated with prostate cancer
- Journal / Conference
- Journal of Clinical Oncology Apr 20;39(12):1339-1348
- Year
- 2021
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID33729825
- PMC
- PMC8078474